Last updated on May 2018

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia


Brief description of study

This study will evaluates the safety and efficacy of Chimeric antigen receptor T cells (CAR-T) in treating central nervous system B-cell acute lymphocytic leukemia.

Detailed Study Description

CNS leukemia is defined as unequivocal evidence of leukemic blasts in the cerebrospinal fluid by cytology or flow cytometry; cranial palsies or a nonhemorrhagic mass seen in cranial computed tomography or magnetic resonance imaging because of infiltration by leukemia cells

Clinical Study Identifier: NCT03064269

Contact Investigators or Research Sites near you

Start Over

Depei Wu, Ph.D

The First Affiliated Hospital of Soochow University
Suzhou, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.